Accord Healthcare US Relaunches Tadalafil Tablets, Broadening Availability of Approved Dosage Strengths

RALEIGH, N.C., May 4, 2026 /PRNewswire/ -- Accord Healthcare, Inc., a leading generic pharmaceutical company, committed to improving access to affordable medicines, today announced the relaunch of Tadalafil Tablets, an FDA-approved phosphodiesterase type 5 (PDE5) inhibitor for oral...